Multi-Target Neural Differentiation (MTND) Therapeutic Cocktail to Suppress Brain Tumor
Brain tumors have been proved challenging to treat. Here we established a Multi-Target Neural Differentiation (MTND) therapeutic cocktail to achieve effective and safe treatment of brain malignancies by targeting the important hallmarks in brain cancers: poor cell differentiation and compromised cel...
Main Authors: | Xiaoping Hu, Jingdun Xie, Yilin Yang, Ziyi Qiu, Weicheng Lu, Xudong Lin, Bingzhe Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/15/12329 |
Similar Items
-
The progress of microenvironment-targeted therapies in brain metastases
by: Lifu Long, et al.
Published: (2023-03-01) -
Editorial: The advances in proteomics and targeted therapy of malignant brain tumours
by: Anjing Chen, et al.
Published: (2023-04-01) -
Targeted Glioma Therapy—Clinical Trials and Future Directions
by: Aleksandr Shikalov, et al.
Published: (2024-01-01) -
Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
by: Giuseppe Lombardi, et al.
Published: (2021-09-01) -
Editorial: Advances in brain tumors diagnosis and treatment
by: Dario de Biase, et al.
Published: (2023-05-01)